Capricor Therapeutics, Inc. (CAPR)
32.11
+1.99
(+6.61%)
USD |
NASDAQ |
Apr 02, 16:00
31.50
-0.61
(-1.90%)
After-Hours: 20:00
Capricor Therapeutics Shareholders Equity (Quarterly) : 305.79M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 24.10M |
| Vaxart, Inc. | 87.80M |
| Allogene Therapeutics, Inc. | 292.54M |
| REGENXBIO, Inc. | 102.73M |
| Replimune Group, Inc. | 210.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 359.95M |
| Total Liabilities (Quarterly) | 54.15M |
| Debt to Equity Ratio | 0.0587 |
| Current Ratio | 9.011 |
| Net Debt Paydown Yield | -0.16% |